These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8440765)

  • 1. Pharmacokinetics of beta-methyldigoxin in subjects with normal and impaired renal function.
    Tsutsumi K; Nakashima H; Tateishi T; Imagawa M; Nakano S
    J Clin Pharmacol; 1993 Feb; 33(2):154-60. PubMed ID: 8440765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and beta-methyldigoxin in rats.
    Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
    J Pharm Sci; 2003 Jul; 92(7):1455-63. PubMed ID: 12820149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of beta-methyl-digoxin in different degrees of renal function (author's transl)].
    Angelino PF; Matta F; Ladetto P
    Med Clin (Barc); 1979 Mar; 72(5):210-6. PubMed ID: 431186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of beta-methyldigoxin and its metabolites by high-performance liquid chromatography and fluorescence polarization immunoassay.
    Nakashima H; Tsutsumi K; Hashiguchi M; Kumagai Y; Ebihara A
    J Chromatogr; 1989 Apr; 489(2):425-31. PubMed ID: 2666425
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T; Ohta H; Maekawa M; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Kawabata M; Hashimoto N
    Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC; Pue MA; Freed MI; Audet PR; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and beta-methyldigoxin in rats.
    Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
    J Pharm Sci; 2005 Jun; 94(6):1196-203. PubMed ID: 15858844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum digoxin and beta-methyldigoxin in elderly patients on hospital admission: correlation with home compliance and clinical variables.
    Seghieri G; Bartolomei GC; De Giorgio LA; Innocenti F; Gironi A; Mian M; Franconi F
    Eur J Clin Pharmacol; 1989; 37(4):401-4. PubMed ID: 2598974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of food on the absorption of beta-methyldigoxin.
    Tsutsumi K; Nakashima H; Kotegawa T; Nakano S
    J Clin Pharmacol; 1992 Feb; 32(2):157-62. PubMed ID: 1613126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of the gastric acidity on the digoxinemia. Comparison between digoxin and beta-methyldigoxin (author's transl)].
    Pasotti C; Rossi R; Zanetta R
    G Ital Cardiol; 1980; 10(12):1669-74. PubMed ID: 7250591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variances in pharmacokinetic parameters due to assay methods for beta-methyldigoxin.
    Goto M; Suzuki A; Terashima T; Johno I; Kitazawa S
    J Pharmacobiodyn; 1987 May; 10(5):209-14. PubMed ID: 3305859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of guanadrel in subjects with normal and impaired renal function.
    Halstenson CE; Opsahl JA; Abraham PA; Schwenk MH; Andreadis NA; Antal EJ; Matzke GR
    J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between renal function and disposition of oral ciprofloxacin.
    Forrest A; Weir M; Plaisance KI; Drusano GL; Leslie J; Standiford HC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1537-40. PubMed ID: 3190182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function.
    Pearson JG; Antal EJ; Raehl CL; Gorsch HK; Craig WA; Albert KS; Welling PG
    Clin Pharmacol Ther; 1986 Mar; 39(3):318-24. PubMed ID: 3081293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of minoxidil in patients with various degrees of renal function.
    Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR
    J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in metildigoxin pharmacokinetics in cirrhosis of the liver: a comparison with beta-acetyldigoxin.
    Rameis H; Woodcock B; Bonelli J; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):145-51. PubMed ID: 6715083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetics in patients with various degrees of renal function.
    Rodvold KA; Blum RA; Fischer JH; Zokufa HZ; Rotschafer JC; Crossley KB; Riff LJ
    Antimicrob Agents Chemother; 1988 Jun; 32(6):848-52. PubMed ID: 3415206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.